Academic literature on the topic 'Akt'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Akt.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Akt"
Matheny, Ronald W., and Martin L. Adamo. "Current Perspectives on Akt Akt-ivation and Akt-ions." Experimental Biology and Medicine 234, no. 11 (November 2009): 1264–70. http://dx.doi.org/10.3181/0904-mr-138.
Full textGömöri, George, and Piroska Szántó. "Akt." World Literature Today 70, no. 1 (1996): 212. http://dx.doi.org/10.2307/40151976.
Full textKotecha, Anish. "AKT question relating to Mental Health Act." InnovAiT: Education and inspiration for general practice 10, no. 11 (October 13, 2017): e139-e139. http://dx.doi.org/10.1177/1755738017728167.
Full textAbdel Kerim, Yasser. "AKT question relating to Mental Health Act." InnovAiT: Education and inspiration for general practice 10, no. 11 (October 13, 2017): e147-e147. http://dx.doi.org/10.1177/1755738017728180.
Full textDunn, Ewan F., Rachel Fearns, and John H. Connor. "Akt Inhibitor Akt-IV Blocks Virus Replication through an Akt-Independent Mechanism." Journal of Virology 83, no. 22 (September 9, 2009): 11665–72. http://dx.doi.org/10.1128/jvi.01092-09.
Full textDanwerth, Christopher. "Die virtuelle Hauptversammlung – Dritter Akt! Letzter Akt?" Die Aktiengesellschaft 66, no. 19 (October 1, 2021): r283—r284. http://dx.doi.org/10.9785/ag-2021-661903.
Full textKumar, Chandra C., and Vincent Madison. "AKT crystal structure and AKT-specific inhibitors." Oncogene 24, no. 50 (November 2005): 7493–501. http://dx.doi.org/10.1038/sj.onc.1209087.
Full textNandakumar, Michael. "AKT question relating to the Mental Capacity Act." InnovAiT: Education and inspiration for general practice 7, no. 12 (December 2014): 767. http://dx.doi.org/10.1177/1755738014557737.
Full textAbdel Kerim, Yasser. "AKT question relating to Mental Health Act assessments." InnovAiT: Education and inspiration for general practice 10, no. 11 (October 13, 2017): e145-e145. http://dx.doi.org/10.1177/1755738017728178.
Full textNandakumar, M. "AKT question relating to Mental Health Act 2007." InnovAiT 4, no. 5 (May 1, 2011): 287. http://dx.doi.org/10.1093/innovait/inr077.
Full textDissertations / Theses on the topic "Akt"
Mahnel, Petr. "Optimalizace výroby firmy AKT." Master's thesis, Vysoká škola ekonomická v Praze, 2009. http://www.nusl.cz/ntk/nusl-72128.
Full textAiken, Andrew. "AKT-R4 a diagnosis tool." Thesis, Available from the University of Aberdeen Library and Historic Collections Digital Resources, 2008. http://digitool.abdn.ac.uk:80/webclient/DeliveryManager?application=DIGITOOL-3&owner=resourcediscovery&custom_att_2=simple_viewer&pid=25223.
Full textMeadows, Kafi, Seema Iyer, Mark Stevens, Duanning Wang, Sharon Shechter, Carole Perruzzi, Todd Camenisch, and Laura Benjamin. "Akt promotes Endocardial-Mesenchyme Transition." BioMed Central, 2009. http://hdl.handle.net/10150/610167.
Full texthowever, the mechanisms driving the initial commitment decision of endothelial cells to EndMT have been difficult to separate from processes required for mesenchymal proliferation and migration. We have several lines of evidence that suggest a central role for Akt signaling in committing endothelial cells to enter EndMT. Akt1 mRNA was restricted to the endocardium of endocardial cushions while they were forming. The PI3K/Akt signaling pathway is necessary for mesenchyme outgrowth, as sprouting was inhibited in AVC explant cultures treated with the PI3K inhibitor LY294002. Furthermore, endothelial marker, VE-cadherin, was downregulated and mesenchyme markers, N-cadherin and Snail, were induced in response to expression of a constitutively active form of Akt1 (myrAkt1) in endothelial cells. Finally, we isolated the function of Akt1 signaling in the commitment to the transition using a transgenic model where myrAkt1 was pulsed only in endocardial cells and turned off after EndMT initiation. In this way, we determined that increased Akt signaling in the endocardium drives EndMT and discounted its other functions in cushion mesenchymal cells.
Park, Sungman. "AKT function and human oncogenesis." [Tampa, Fla.] : University of South Florida, 2007. http://purl.fcla.edu/usf/dc/et/SFE0001885.
Full textPalková, Anežka. "Spolupráce EU - AKT na příkladu Haiti." Master's thesis, Vysoká škola ekonomická v Praze, 2011. http://www.nusl.cz/ntk/nusl-113492.
Full textMiddel, Ines Kristin. "Quantitative Untersuchung der Proteinkinase AKT am Ovarialkarzinom." Köln Deutsche Zentralbibliothek für Medizin, 2010. http://d-nb.info/1000727416/34.
Full textNg, Foong Loo Yvonne Biotechnology & Biomolecular Sciences Faculty of Science UNSW. "Insulin action: unravelling AKT signalling in Adipocytes." Awarded by:University of New South Wales. Biotechnology & Biomolecular Sciences, 2009. http://handle.unsw.edu.au/1959.4/44628.
Full textRickle, Annika. "PTEN and Akt signalling in Alzheimer's disease /." Stockholm : Karolinska institutet, 2005. http://diss.kib.ki.se/2005/91-7140-514-3/.
Full textHiester, Andreas [Verfasser]. "Proteininteraktion der Proteinkinase AKT 1 / Andreas Hiester." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2014. http://d-nb.info/1046174215/34.
Full textFedrigo, Carlos Alexandre. "Inibição da via PI3K-Akt em gliomas." Pontifícia Universidade Católica do Rio Grande do Sul, 2012. http://hdl.handle.net/10923/4518.
Full textGlioblastoma multiforme (GMB) is the most malignant and common type of all astrocytic tumours. Current standard treatment for GBM patients involves maximum surgical resection of the tumour, followed by radiotherapy and chemotherapy, usually containing the alkylating agent Temozolomide (TMZ). Despite this aggressive combination therapy, the survival rate of GBM patients is still low. This work consisted in investigating the cytotoxic effects of Akt-inhibition by MK-2206 with irradiation (RT) and TMZ on in vitro human malignant glioma. Seven malignant glioma cell lines were cultured and tested for clonogenic survival, invasion inhibition, tumour spheroid growth and proliferation. The Akt-inhibitor MK-2206 and TMZ were added at different time treatments and in varying doses. Cultures were irradiated with single dose and with fractionated γ-irradiation. Cellular modulation of Akt and p-Akt were assessed by Western blot analysis. MK-2206 reduced the levels of phospho- Akt key protein in the PI3Kinase-Akt pathway, decreased cell survival, and inhibited invasion, proliferation and cell growth. The combination of MK-2206 and RT lead to enhanced inhibition of cell proliferation and invasion, which is not observed with RT alone. The radioenhancing effect of MK-2206 was most striking in inhibition of spheroid volume growth by fractionated RT; the radiosensitizing effect of MK-2206 was stronger than that of TMZ. MK-2206 enhanced the in vitro effects of RT and TMZ in terms of decreased cell survival, invasion, proliferation and growth in malignant glioma. Effects could be ascribed to inhibition of PI3K-Akt pathway.
O Glioblastoma multiforme (GBM) é o tipo mais maligno e mais comum de todos tumores astrocíticos. O tratamento atual para pacientes de GBM envolve máxima remoção cirúrgica, seguida de radio e quimioterapia, normalmente com o agente alquilante Temozolamida (TMZ). Apesar da agressividade da terapia combinada, o tempo de sobrevivência dos pacientes ainda é baixo. Este trabalho procurou investigar os efeitos citotóxicos do inibidor de Akt MK-2206 em combinação com irradiação (RT) e TMZ em um painel de células de gliomas humanos. Sete linhagens de glioma foram cultivadas e testadas em ensaio de sobrevivência clonogênica, inibição de invasão, e modelos de proliferação e crescimento de volume em esferóides. O inibidor MK-2206 e TMZ foram adicionados em diferentes tempos de tratamento e diferentes doses. As culturas foram irradiadas com doses únicas ou em terapias fracionadas com irradiação γ. A modulação celular de Akt e fosfo-Akt foi checada via Western Blot. O composto MK-2206 reduziu a fosforilação da proteína chave Akt na via PI3K, diminuindo a sobrevivência celular e inibindo invasão, proliferação e crescimento celular. A combinação de MK-2206 com RT levou a uma maior inibição de invasão e proliferação, o que não é observado somente com a RT. O efeito radiosensível de MK-2206 foi ainda maior na inibição do volume dos esferóides em terapia combinada com RT fracionada, sendo ainda maior do que o efeito combinado com TMZ. MK-2206 aumentou os efeitos in vitro de RT e TMZ em termos de redução de sobrevivência celular, invasão, proliferação e crescimento celular em gliomas malignos. Os efeitos podem ser atribuídos a inibição da via PI3KAkt.
Books on the topic "Akt"
Szántó, Piroska. Akt. Budapest: Európa, 1994.
Find full textFösterling, Hermann. Akt. Frankfurt Main: Umschau/Braus, 2000.
Find full textDugalić, Ljiljana. Akt. 2nd ed. Beograd: Ljiljana Dugalić, 2008.
Find full text1936-, Dabo Radoslav, and Čegec Branko, eds. Akt. Zagreb: Meandar, 1999.
Find full textDugalić, Ljiljana. Akt. 2nd ed. Beograd: Ljiljana Dugalić, 2008.
Find full textJutarnyj akt. Beograd: Čigoja štampa, 2000.
Find full textKrolikowski, Bohdan. Akt oskarzenia. Lublin: Wydawnictwo Katolickiego Uniwersytetu Lubelskiego, 2007.
Find full textAkt oskarżenia. Lublin: Wydawnictwo KUL, 2007.
Find full textStalev, Zhivko Stoi︠a︡nov. Notarialnii︠a︡t akt. 2nd ed. Sofii︠a︡: Izdatelstvo za pravna literatura "Fenei︠a︡", 2004.
Find full textJanssen, Sammlung. Manner Akt. Berlin: Janssen Verlag, 1992.
Find full textBook chapters on the topic "Akt"
Blaustein, Matías. "AKT." In Encyclopedia of Signaling Molecules, 267–80. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101974.
Full textYap, Timothy A., and Johann S. de Bono. "AKT." In Cancer Therapeutic Targets, 3–12. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4419-0717-2_35.
Full textBlaustein, Matías. "AKT." In Encyclopedia of Signaling Molecules, 1–14. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-6438-9_101974-1.
Full textYap, Timothy A., and Johann S. de Bono. "AKT." In Cancer Therapeutic Targets, 1–10. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-6613-0_35-5.
Full textLœffler, Peter. "Akt I." In Guillaume Apollinaire die Brueste des Tiresias, 22–48. Basel: Birkhäuser Basel, 1989. http://dx.doi.org/10.1007/978-3-0348-6636-1_4.
Full textLœffler, Peter. "Akt II." In Guillaume Apollinaire die Brueste des Tiresias, 49–75. Basel: Birkhäuser Basel, 1989. http://dx.doi.org/10.1007/978-3-0348-6636-1_5.
Full textKrebs, Anna-Maria, and Oliver Gollanek. "Dritter Akt." In Die Digitalisierung und der Faktor Mensch, 117–38. Wiesbaden: Springer Fachmedien Wiesbaden, 2019. http://dx.doi.org/10.1007/978-3-658-27992-9_6.
Full textFriedl, Christian. "Der erste Akt." In Hollywood im journalistischen Alltag, 1–120. Wiesbaden: Springer Fachmedien Wiesbaden, 2017. http://dx.doi.org/10.1007/978-3-658-16674-8_1.
Full textFriedl, Christian. "Der zweite Akt." In Hollywood im journalistischen Alltag, 121–232. Wiesbaden: Springer Fachmedien Wiesbaden, 2017. http://dx.doi.org/10.1007/978-3-658-16674-8_2.
Full textFriedl, Christian. "Der dritte Akt." In Hollywood im journalistischen Alltag, 233–89. Wiesbaden: Springer Fachmedien Wiesbaden, 2017. http://dx.doi.org/10.1007/978-3-658-16674-8_3.
Full textConference papers on the topic "Akt"
Nag, Arundhati. "Abstract 2172: Circle Akt in: Epitope catalyzed assembly of macrocyclic therapeutics against phosphorylated Akt." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2172.
Full textBerndt, Norbert, Hua Yang, Bernard Trinczek, Ziming Zhang, Bainan Wu, Nicholas J. Lawrence, Maurizio Pellechia, Ernst Schonbrunn, Jin Q. Cheng, and Said M. Sebti. "Abstract 3680: The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-3680.
Full textNi, Qiang, Matthew Fosbrink, and Jin Zhang. "Illuminating the phosphatidylinositol 3-kinase/Akt pathway." In Biomedical Optics (BiOS) 2008, edited by Alexander P. Savitsky, Robert E. Campbell, and Robert M. Hoffman. SPIE, 2008. http://dx.doi.org/10.1117/12.765524.
Full textAli, Amna, and Diane F. Matesic. "Abstract 4523: Chaetoglobosin K, a dual Akt and JNK inhibitor, modulates Akt phosphorylation in an mTORC2 independent manner." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-4523.
Full textEllington, Allison, Seamus Webb, Thomas Miller, Paula Eason, Leonid Dzantiev, Sripriya Ranganathan, Laura Schaefer, Pankaj Oberoi, and Jacob N. Wohlstadter. "Abstract 5159: Quantitative immunoassays to measure total Akt-1 and phospho-Akt(Ser473) in cell and tissue lysate models." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5159.
Full textChebotariova, Nataliia Andreevna. "Arkhitektura kak akt kommunikatsii v rabotakh Umberto Eko." In IV International Research-to-practice conference. TSNS Interaktiv Plus, 2018. http://dx.doi.org/10.21661/r-469450.
Full textLi, Y., Y. Yang, Y. W. Wang, F. S. Shi, Y. Zhang, H. W. Wen, Q. Wang, J. Yang, L. Wang, and G. Yu. "TRIM36 Degrades Phosphorylated AKT to Suppress Pulmonary Fibrosis." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a2466.
Full textRajesh, SA, L. Coltan, A. Barr, JR Dyck, F. Eaton, and B. Thebaud. "Akt Activation Protects Lung Alveoli from Oxidant-Induced Injury." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1970.
Full textBryant, Latoya K., Kia J. Jones, and Cimona V. Hinton. "Abstract 501: CXCR4 induced ROS accumulation through PI3K/AKT." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-501.
Full textSpirina, L. V., Y. A. Usynin, I. V. Kondakova, Z. A. Yurmazov, E. M. Slonimskaya, and E. S. Kolegova. "The AKT-mTOR signalling pathway in kidney cancer tissues." In NEW OPERATIONAL TECHNOLOGIES (NEWOT’2015): Proceedings of the 5th International Scientific Conference «New Operational Technologies». AIP Publishing LLC, 2015. http://dx.doi.org/10.1063/1.4936067.
Full textReports on the topic "Akt"
Baldwin, Albert S. Control of Akt Activity in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, February 2009. http://dx.doi.org/10.21236/ada512632.
Full textChang, Chawnshang. Suppression of Androgen Receptor Transactivation by Akt Kinase. Fort Belvoir, VA: Defense Technical Information Center, January 2005. http://dx.doi.org/10.21236/ada444244.
Full textHager, Martin H. Membrane Heterogeneity in Akt Activation in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, March 2008. http://dx.doi.org/10.21236/ada484355.
Full textChung, Jun, and Arthur M. Mercurio. Integrin Regulation of Akt and Breast Cancer Metastasis. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada407289.
Full textRoper, Jatin. The Role of Akt Isoforms in Colorectal Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2014. http://dx.doi.org/10.21236/ada613186.
Full textHager, Martin H. Membrane Heterogeneity in Akt Activation in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, November 2009. http://dx.doi.org/10.21236/ada538836.
Full textHager, Martin H. Membrane Heterogeneity in Akt Activation in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, March 2009. http://dx.doi.org/10.21236/ada504765.
Full textHager, Martin H. Membrane Heterogeneity in Akt Activation in Prostate Cancer. Fort Belvoir, VA: Defense Technical Information Center, July 2009. http://dx.doi.org/10.21236/ada510139.
Full textChang, Chanshang. Suppression of Androgen Receptor Transactivation by Akt Kinase. Fort Belvoir, VA: Defense Technical Information Center, January 2004. http://dx.doi.org/10.21236/ada423309.
Full textShareef, Mohammed M., Biju Isaac, Sakhi Philip, Thirupandiyur Udayakumar, and Alan Pollack. AKT in Differential miRNA Processing in Prostate Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, September 2013. http://dx.doi.org/10.21236/ada593281.
Full text